MAPT and Alzheimer disease: However, some studies revealed that in the entorhinal cortex (EC)—where tau pathology first emerges—the level of tau phosphorylation in PART can surpass that observed in AD.[14] This suggests the possible presence of a potent driver of tau phosphorylation in the EC region of PART patients, independent of Aβ‐mediated mechanisms.